|

Pocenbrodib Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Pathos AI, Inc.1

Indications

  • Male Urogenital Diseases1
  • Prostatic Diseases1
  • Urogenital Cancers1
  • Urogenital Neoplasms1
  • Genital Neoplasms, Male1

Fountain Valley, California1 trial

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

MemorialCare Orange Coast Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.